Michelle E. Armstrong

1.6k total citations
35 papers, 1.2k citations indexed

About

Michelle E. Armstrong is a scholar working on Immunology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michelle E. Armstrong has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 11 papers in Epidemiology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michelle E. Armstrong's work include Macrophage Migration Inhibitory Factor (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers) and Sarcoidosis and Beryllium Toxicity Research (4 papers). Michelle E. Armstrong is often cited by papers focused on Macrophage Migration Inhibitory Factor (13 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers) and Sarcoidosis and Beryllium Toxicity Research (4 papers). Michelle E. Armstrong collaborates with scholars based in Ireland, United States and United Kingdom. Michelle E. Armstrong's co-authors include Seamas C. Donnelly, Gordon Cooke, Kingston H. G. Mills, Ed C. Lavelle, David N. O’Dwyer, Padraic G. Fallon, Sarah Higgins, Olive Leavy, Edel A. McNeela and Emily Hams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Michelle E. Armstrong

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle E. Armstrong Ireland 17 676 365 185 168 168 35 1.2k
Jennifer Heimall United States 24 935 1.4× 238 0.7× 211 1.1× 258 1.5× 135 0.8× 77 1.7k
H. C. Hoogsteden Netherlands 21 537 0.8× 468 1.3× 72 0.4× 150 0.9× 404 2.4× 37 1.2k
Holger Bartz Germany 15 674 1.0× 191 0.5× 84 0.5× 134 0.8× 118 0.7× 20 1.1k
Rosa Ten United States 20 741 1.1× 212 0.6× 176 1.0× 390 2.3× 295 1.8× 28 1.5k
Damian M. Carragher United States 13 1.1k 1.6× 125 0.3× 157 0.8× 246 1.5× 157 0.9× 18 1.6k
Regina Maus Germany 22 1.0k 1.5× 494 1.4× 92 0.5× 331 2.0× 210 1.3× 44 1.8k
Katrijn Neyt Belgium 6 906 1.3× 110 0.3× 82 0.4× 164 1.0× 289 1.7× 7 1.2k
Ana Paula Moreira Brazil 14 548 0.8× 180 0.5× 79 0.4× 156 0.9× 168 1.0× 20 1.0k
Belinda J. Thomas Australia 15 296 0.4× 270 0.7× 87 0.5× 319 1.9× 175 1.0× 20 1.0k
Jennifer Louten United States 11 780 1.2× 203 0.6× 136 0.7× 225 1.3× 99 0.6× 14 1.2k

Countries citing papers authored by Michelle E. Armstrong

Since Specialization
Citations

This map shows the geographic impact of Michelle E. Armstrong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle E. Armstrong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle E. Armstrong more than expected).

Fields of papers citing papers by Michelle E. Armstrong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle E. Armstrong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle E. Armstrong. The network helps show where Michelle E. Armstrong may publish in the future.

Co-authorship network of co-authors of Michelle E. Armstrong

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle E. Armstrong. A scholar is included among the top collaborators of Michelle E. Armstrong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle E. Armstrong. Michelle E. Armstrong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tran, Thuy, Lais Osmani, Marta Piecychna, et al.. (2025). Improving immunotherapy responses by dual inhibition of macrophage migration inhibitory factor and PD-1. JCI Insight. 10(20).
2.
McNamee, Eóin N., et al.. (2024). The human MIF polymorphism CATT 7 enhances pro‐inflammatory macrophage polarization in a clinically relevant model of allergic airway inflammation. The FASEB Journal. 38(6). e23576–e23576. 5 indexed citations
3.
Obéid, Michel, Thomas Bütler, Michelle E. Armstrong, et al.. (2024). Fibroblast activation in sarcoidosis as assessed by 68Ga-FAPI (fibroblast activation protein inhibitor)-46 PET/CT. QJM. 117(8). 603–604. 1 indexed citations
4.
Li, Jia, Lin Leng, Georgios Pantouris, et al.. (2024). A small-molecule allele-selective transcriptional inhibitor of the MIF immune susceptibility locus. Journal of Biological Chemistry. 300(7). 107443–107443. 2 indexed citations
5.
6.
Armstrong, Michelle E., et al.. (2023). Blockade of MIF biological activity ameliorates house dust mite‐induced allergic airway inflammation in humanized MIF mice. The FASEB Journal. 37(8). e23072–e23072. 5 indexed citations
7.
Weiss, Daniel J., Sara Rolandsson Enes, Claúdia C. dos Santos, et al.. (2023). Human macrophage migration inhibitory factor potentiates mesenchymal stromal cell efficacy in a clinically relevant model of allergic asthma. Molecular Therapy. 31(11). 3243–3258. 10 indexed citations
8.
Invernizzi, Rachele, Mohammad Doroudian, Mohsen Moghoofei, et al.. (2022). Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 205(5). 550–562. 16 indexed citations
9.
Doroudian, Mohammad, Ciaran O’Reilly, Leona Mawhinney, et al.. (2020). Aerosolized Drug-Loaded Nanoparticles Targeting Migration Inhibitory Factors Inhibit Pseudomonas Aeruginosa -Induced Inflammation and Biofilm Formation. Nanomedicine. 15(30). 2933–2953. 25 indexed citations
10.
Mawhinney, Leona, Michelle E. Armstrong, Ciaran O’Reilly, et al.. (2014). Macrophage Migration Inhibitory Factor (MIF) Enzymatic Activity and Lung Cancer. Molecular Medicine. 20(1). 729–735. 53 indexed citations
11.
O’Dwyer, David N., Michelle E. Armstrong, Glenda Trujillo, et al.. (2013). The Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 188(12). 1442–1450. 123 indexed citations
12.
Cooke, Gordon, Praveen Govender, Chris Watson, et al.. (2013). Sarcoidosis, alveolar  -actin and pulmonary fibrosis. QJM. 106(10). 897–902. 9 indexed citations
13.
Adamali, Huzaifa, Michelle E. Armstrong, Anne Marie McLaughlin, et al.. (2012). Macrophage Migration Inhibitory Factor Enzymatic Activity, Lung Inflammation, and Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 186(2). 162–169. 43 indexed citations
14.
15.
Cooke, Gordon, Michelle E. Armstrong, & Seamas C. Donnelly. (2009). Macrophage migration inhibitory factor (MIF), enzymatic activity and the inflammatory response. BioFactors. 35(2). 165–168. 48 indexed citations
16.
Armstrong, Michelle E., Michael P. Gantier, Lili Li, et al.. (2008). Small Interfering RNAs Induce Macrophage Migration Inhibitory Factor Production and Proliferation in Breast Cancer Cells via a Double-Stranded RNA-Dependent Protein Kinase-Dependent Mechanism. The Journal of Immunology. 180(11). 7125–7133. 32 indexed citations
17.
Lavelle, Ed C., Edel A. McNeela, Michelle E. Armstrong, et al.. (2003). Cholera Toxin Promotes the Induction of Regulatory T Cells Specific for Bystander Antigens by Modulating Dendritic Cell Activation. The Journal of Immunology. 171(5). 2384–2392. 121 indexed citations
18.
Armstrong, Michelle E., Christine E. Loscher, Marina A. Lynch, & Kingston H. G. Mills. (2003). IL-1β-dependent neurological effects of the whole cell pertussis vaccine: a role for IL-1-associated signalling components in vaccine reactogenicity. Journal of Neuroimmunology. 136(1-2). 25–33. 17 indexed citations
19.
Armstrong, Michelle E.. (2003). Growth factor modulation of the extracellular matrix. Experimental Cell Research. 288(2). 235–245. 3 indexed citations
20.
Armstrong, Michelle E., et al.. (2001). Age-Related Alterations in Basal Expression and in vitro, Tumour Necrosis Factor Alpha Mediated, Upregulation of CD11b. Gerontology. 47(4). 180–185. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Heimall Breakdown of academic impact, for papers by H. C. Hoogsteden Breakdown of academic impact, for papers by Holger Bartz Breakdown of academic impact, for papers by Rosa Ten Breakdown of academic impact, for papers by Damian M. Carragher Breakdown of academic impact, for papers by Regina Maus Breakdown of academic impact, for papers by Katrijn Neyt Breakdown of academic impact, for papers by Ana Paula Moreira Breakdown of academic impact, for papers by Belinda J. Thomas Breakdown of academic impact, for papers by Jennifer Louten
Rankless by CCL
2026